#1 Clinical Trials Search in Europe

Methotrexate

Methotrexate is a versatile drug that has been the subject of numerous clinical trials for treating various medical conditions. This article explores the use of methotrexate in clinical studies for conditions such as rheumatoid arthritis, psoriasis, ectopic pregnancy, and gestational trophoblastic neoplasia. We’ll examine the drug’s efficacy, safety, and potential new applications as revealed by recent clinical research.

Table of Contents

What is Methotrexate?

Methotrexate is a versatile medication used to treat various conditions. It is known by several other names, including MTX, amethopterin, and Trexall®[1]. Methotrexate belongs to a class of drugs called antimetabolites, which work by interfering with the growth of certain cells in the body[2].

Conditions Treated with Methotrexate

Methotrexate is used to treat a wide range of conditions, including:

  • Rheumatoid Arthritis: A chronic inflammatory disorder affecting the joints[3]
  • Crohn’s Disease: A type of inflammatory bowel disease[4]
  • Certain types of cancer: Including leukemia, lymphoma, and ovarian cancer[1][5]
  • Large Granular Lymphocyte (LGL) Leukemia: A rare type of blood cancer[6]
  • Alopecia Areata: An autoimmune disorder causing hair loss[7]
  • Colorectal Cancer: When used in combination with other medications[8]

How Methotrexate Works

Methotrexate works in different ways depending on the condition being treated:

  • For cancer: It interferes with the growth of cancer cells, stopping them from dividing and multiplying[5].
  • For autoimmune conditions: It suppresses the immune system, reducing inflammation and slowing down the progression of the disease[3].
  • For LGL Leukemia: It helps normalize blood cell counts and reduce symptoms associated with the disease[6].

How Methotrexate is Administered

Methotrexate can be administered in several ways:

  • Oral tablets: Taken by mouth, often on a weekly basis[6]
  • Injections: Given under the skin (subcutaneous) or into a muscle[9]
  • Intravenous infusion: Delivered directly into a vein[3]

The dosage and frequency of administration depend on the condition being treated and the patient’s response to the medication. For example, in rheumatoid arthritis, a common dosage is 7.5-25 mg per week[3].

Methotrexate in Combination Therapies

Methotrexate is often used in combination with other medications to enhance its effectiveness:

  • With biological drugs like infliximab or ocrelizumab for rheumatoid arthritis[3]
  • As part of a “metronomic” chemotherapy regimen for colorectal cancer, combined with drugs like capecitabine, cyclophosphamide, and celecoxib[8]
  • With sirolimus for certain types of leukemia and lymphoma[1]

Potential Side Effects

Like all medications, methotrexate can cause side effects. Common side effects may include:

  • Nausea and vomiting
  • Fatigue
  • Mouth sores
  • Increased risk of infections
  • Liver function abnormalities

To minimize side effects, doctors often prescribe folic acid supplements to patients taking methotrexate[3]. It’s important to discuss potential side effects with your healthcare provider and report any unusual symptoms promptly.

Ongoing Research and Future Directions

Researchers continue to study methotrexate to find new uses and improve its effectiveness:

  • Investigating its use in combination with other drugs for various types of cancer[1]
  • Exploring its effectiveness in treating alopecia areata (hair loss)[7]
  • Studying different dosing regimens to optimize treatment for conditions like LGL leukemia[6]

These ongoing studies aim to expand our understanding of methotrexate and improve treatment outcomes for patients with various conditions.

Condition Study Type Key Findings/Objectives
Rheumatoid Arthritis Randomized, double-blind, placebo-controlled Evaluating efficacy and safety of BCD-089 (IL-6 receptor antibody) in combination with methotrexate
Psoriasis (Fingernail) Phase IIB dose-response study Comparing efficacy and safety of three concentrations of topical methotrexate
Ectopic Pregnancy Randomized clinical trial Comparing oral letrozole to intramuscular methotrexate for early ectopic pregnancy treatment
Chronic Urticaria Randomized, double-blind, placebo-controlled Assessing efficacy of methotrexate in addition to anti-H1 for severe chronic idiopathic urticaria
Nasal Polyposis Randomized, controlled trial Comparing methotrexate to methylprednisolone and standard treatment for maintenance therapy
Gestational Trophoblastic Neoplasia Randomized phase III trial Comparing effectiveness of methotrexate vs dactinomycin in low-risk cases

FAQ

  • What is methotrexate and how does it work? Methotrexate is an anti-metabolite drug that inhibits dihydrofolate reductase. It is used to treat various conditions, including certain cancers, autoimmune diseases, and ectopic pregnancies. Methotrexate works by interfering with cell growth and division, which can help reduce inflammation and suppress the immune system in certain conditions.
  • In which medical conditions is methotrexate being studied? Clinical trials are exploring the use of methotrexate in various conditions, including rheumatoid arthritis, psoriasis, ectopic pregnancy, chronic urticaria, nasal polyposis, and gestational trophoblastic neoplasia. These studies aim to evaluate its efficacy, safety, and potential new applications.
  • How is methotrexate administered in clinical trials? Methotrexate can be administered in different ways depending on the condition being treated and the specific trial. Common methods include oral tablets, intramuscular injections, and topical applications. The dosage and frequency of administration vary based on the study protocol and the condition being treated.
  • What are some potential side effects of methotrexate? Common side effects of methotrexate may include nausea, fatigue, and mouth sores. More serious side effects can include liver damage, bone marrow suppression, and lung problems. Clinical trials closely monitor patients for adverse effects and may compare the safety profile of methotrexate to other treatments or placebos.
  • How do researchers measure the effectiveness of methotrexate in clinical trials? Researchers use various measures to assess methotrexate's effectiveness, depending on the condition being studied. These may include changes in disease activity scores, improvement in symptoms, reduction in inflammation markers, or changes in specific biomarkers. For example, in rheumatoid arthritis trials, researchers might use measures like the DAS28-CRP score or ACR response criteria.

Ongoing Clinical Trials on Methotrexate

  • Study on the Effectiveness and Safety of Cyclosporine and Methotrexate for Children and Adolescents with Moderate to Severe Atopic Dermatitis

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Poland

  • Study for Adults with Very High-Risk T-Cell Acute Lymphoblastic Leukemia Using Daratumumab and a Drug Combination

    Not recruiting

    1 1 1
    Investigated drugs:
    Italy

  • Study Comparing Rituximab with Drug Combination for Patients with Newly Diagnosed High-Risk Burkitt Lymphoma

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium The Netherlands

  • Study on Ponatinib and Chemotherapy for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

    Not recruiting

    1 1 1
    Investigated drugs:
    Italy

  • Study on Ponatinib and Blinatumomab for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Italy

  • Study on Rheumatoid Arthritis: Evaluating Methotrexate, Golimumab, and Hydroxychloroquine Sulfate for Patients with Autoantibodies and Response to Glucocorticoids

    Not recruiting

    1 1 1 1
    Investigated drugs:
    The Netherlands

  • Study on the Effects of AP1189 and Methotrexate for Patients with Early Rheumatoid Arthritis and Active Inflammation

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Denmark Poland Romania

  • Study on Methotrexate, Dexamethasone, and Montelukast to Prevent Infusion Reactions in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Spain

  • Study of methotrexate compared to placebo for treating pain in patients with erosive hand osteoarthritis

    Not recruiting

    1 1 1
    Investigated drugs:
    Norway

  • Comparing Methotrexate and Tocilizumab for Treating Giant Cell Arteritis in Patients: A Study on Effectiveness and Safety

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

Glossary

  • Methotrexate: An anti-metabolite drug that inhibits dihydrofolate reductase, used to treat various conditions including certain cancers, autoimmune diseases, and ectopic pregnancies.
  • Rheumatoid Arthritis (RA): A chronic inflammatory disorder that primarily affects joints, causing pain, swelling, and potential joint damage.
  • Psoriasis: A chronic autoimmune condition that causes rapid buildup of skin cells, resulting in scaly, itchy, dry patches on the skin.
  • Ectopic Pregnancy: A pregnancy where the fertilized egg implants outside the uterus, most commonly in the fallopian tube.
  • Chronic Urticaria: A condition characterized by recurring hives or wheals that persist for more than six weeks.
  • Nasal Polyposis: A condition where soft, painless, noncancerous growths develop in the lining of the nasal passages or sinuses.
  • Gestational Trophoblastic Neoplasia: A group of rare tumors that develop in the uterus from placental tissue.
  • DAS28-CRP: Disease Activity Score 28 – C-Reactive Protein, a measure used to assess disease activity in rheumatoid arthritis.
  • ACR Response Criteria: American College of Rheumatology response criteria, used to measure improvement in rheumatoid arthritis symptoms.
  • Bioequivalence: The absence of a significant difference in the rate and extent to which the active ingredient becomes available at the site of drug action when administered in the same dose under similar conditions.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Beta-HCG: Beta Human Chorionic Gonadotropin, a hormone produced during pregnancy that is used as a marker in certain conditions like ectopic pregnancy and gestational trophoblastic neoplasia.

References

  1. https://clinicaltrials.gov/study/NCT01162551
  2. https://clinicaltrials.gov/study/NCT02701517
  3. https://clinicaltrials.gov/study/NCT00808210
  4. https://clinicaltrials.gov/study/NCT01802593
  5. https://clinicaltrials.gov/study/NCT00002487
  6. https://clinicaltrials.gov/study/NCT01976182
  7. https://clinicaltrials.gov/study/NCT02037191
  8. https://clinicaltrials.gov/study/NCT01668680
  9. https://clinicaltrials.gov/study/NCT02269358